Feasibility and Efficacy of Adjuvant Chemotherapy With Gemcitabine After Liver Transplantation for Perihilar Cholangiocarcinoma - A Multi-Center, Randomized, Controlled Trial (pro-duct001)

BACKGROUND: Liver transplantation (LT) is considered a therapeutic option for unresectable perihilar cholangiocarcinoma (PHC) within defined criteria. It remains uncertain whether patients can safely receive adjuvant chemotherapy after LT. METHODS: We performed a prospective, multi-center, randomize...

Descripción completa

Detalles Bibliográficos
Autores principales: Schmelzle, Moritz, Benzing, Christian, Fischer, Lutz, Herden, Uta, Sterneck, Martina, Settmacher, Utz, Bauschke, Astrid, Neumann, Ulf, Pelzer, Uwe, Müller, Tobias, Strassburg, Christian, Lang, Hauke, Becker, Thomas, Königsrainer, Alfred, Nadalin, Silvio, Quante, Markus, Paul, Andreas, Friess, Helmut, Klempnauer, Jürgen, Richter, Nicolas, Vondran, Florian, Pascher, Andreas, Rösch, Thomas, Schöning, Wenzel, Krenzien, Felix, Öllinger, Robert, Seehofer, Daniel, Neuhaus, Peter, Pratschke, Johann
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9624225/
https://www.ncbi.nlm.nih.gov/pubmed/36330499
http://dx.doi.org/10.3389/fonc.2022.910871

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9624225/
https://www.ncbi.nlm.nih.gov/pubmed/36330499
http://dx.doi.org/10.3389/fonc.2022.910871

Ejemplares similares